Dr. Isaac R. Rodriguez-Chavez is a distinguished scientific and regulatory expert with a 30-year career spanning Infectious Diseases, Viral Immunology, Viral Oncology, Microbiology, Vaccinology, and rare diseases. His experience covers the entire life cycle of medical product development from basic, preclinical, interventional clinical research (phase I – IV), non-interventional clinical research, and post-marketing studies leveraging with standard healthcare systems. Currently an independent clinical research, regulatory affairs and digital medicine consultant, he has held influential roles, including Senior Vice President at ICON plc, where he led Decentralized Clinical Trials (DCTs) and Digital Medicine strategies. He made significant contributions as an FDA, CDER Senior Officer, leading work on modernizing clinical research through DCTs and Digital Health Technologies.

Dr. Rodriguez-Chavez is a board member of BlueCloud by HealthCarePoint, Reveles Clinical Research, Digital Medical Society, and the Hypertrophic Cardiomyopathy Association (HCMA). He's also engaged with Global Genes as a Rare Disease Health Equity Council member and serves as a Regulatory Science Editor at the DIA Global Forum Magazine. He actively shapes industry technology standards to assist with the implementation of DCTs and modern trials enabled by digital health technologies as Co-Chair of the Institute of Electrical and Electronics Engineers (IEEE).

His academic background includes a PhD in Virology and Immunology, an MS in Microbiology, an MHS in Clinical Research, and a BS in Biology. With post-doctoral specialty training in Infectious Diseases, Viral Immunology, Viral Oncology, and Clinical Research, he has authored 60+ scientific publications and presented at over 140 global conferences.